Low level HIV viremia is more frequent under protease-inhibitor containing firstline therapy than under NNRTI-regimens

INTRODUCTION: An association of persistent low level viremia (LLV) below 500 copies/mL and a higher risk of therapy failure is still point of controversial discussion. Furthermore, it seems that LLV occurs more frequently in patients with protease-inhibitor regimens than in NNRTI- / or integrase-inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiesmann, Frank, Braun, Patrick, Knickmann, Mechthild, Knechten, Heribert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P296
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225437/
https://www.ncbi.nlm.nih.gov/pubmed/25397572
http://dx.doi.org/10.7448/IAS.17.4.19828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225437/
https://www.ncbi.nlm.nih.gov/pubmed/25397572
http://dx.doi.org/10.7448/IAS.17.4.19828

Ejemplares similares